Affinity Asset Advisors »

Nextcure shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Nextcure shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 192k 5.86

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Nextcure

Sofinnova Ventures
Affinity Asset Advisors
Pfizer
Vanguard Group
Cable Car Capital
Acadian Asset Management
BlackRock
Renaissance Technologies
Geode Capital Management
Sio Capital Management
Barclays
UBS Group
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Nextcure